Bristol-Myers Squibb buy gerihouse
Summary
This prediction ended on 22.07.15 with a price of €62.67. The BUY prediction by gerihouse finished with a performance of 3.33%. gerihouse has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 1.039% | 1.039% | -34.075% | -22.637% |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
According to gerihouse what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Cons
Comments by gerihouse for this prediction
In the thread Bristol-Myers Squibb diskutieren
Nimm das Krebs!
Bristol-Myers Squibb beobachte ich schon längerm, und ich finde es ist an der Zeit eine Buy Empfehlung zu schreiben. Quartalsdividende gibt es Anfang Mai.
Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Credit Suisse from $68.00 to $70.00 in a research report sent to investors on Thursday morning. The firm currently has an outperform rating on the stock.
Bristol-Myers Squibb traded up 0.55% on Thursday, hitting $65.48. The stock had a trading volume of 1,767,733 shares. Bristol-Myers Squibb has a 52 week low of $46.30 and a 52 week high of $67.18. The stock’s 50-day moving average is $61.24 and its 200-day moving average is $56.69. The company has a market cap of $108.8 billion and a price-to-earnings ratio of 54.27.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Tuesday, January 27th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.41 by $0.05. The company had revenue of $4.26 billion for the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter in the prior year, the company posted $0.51 earnings per share. The company’s quarterly revenue was down 4.1% on a year-over-year basis. Analysts expect that Bristol-Myers Squibb will post $1.72 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Monday, April 6th will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Wednesday, April 1st.
